Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Interaction of Interleukin-16 Genotypes With Betel Quid Chewing Behavior on Oral Cancer in Taiwan

LIANG-CHUN SHIH, WEN-SHIN CHANG, HSU-TUNG LEE, YUN-CHI WANG, ZHI-HONG WANG, CHE-YI CHAO, CHIEN-CHIH YU, HUI-YI LIN, TE-CHUN SHEN, CHIEN-CHUNG KUO, CHIA-WEN TSAI and DA-TIAN BAU
In Vivo July 2020, 34 (4) 1759-1764; DOI: https://doi.org/10.21873/invivo.11969
LIANG-CHUN SHIH
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
2Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
3Department of Otolaryngology, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WEN-SHIN CHANG
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
2Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HSU-TUNG LEE
4Cancer Prevention Center, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
5Department of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUN-CHI WANG
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
2Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZHI-HONG WANG
6Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHE-YI CHAO
6Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIEN-CHIH YU
2Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
7School of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HUI-YI LIN
7School of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TE-CHUN SHEN
2Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIEN-CHUNG KUO
2Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: datian@mail.cmuh.org.tw artbau2@gmail.com
CHIA-WEN TSAI
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
2Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: datian@mail.cmuh.org.tw artbau2@gmail.com
DA-TIAN BAU
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
2Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
8Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: datian@mail.cmuh.org.tw artbau2@gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Interleukin-16 (IL-16) is reported to play an important role in inflammation, carcinogenesis and tumoricidal processes, however, the contribution of IL-16 genotype to oral carcinogenesis is still largely unrevealed. Thus, the study aimed to investigate the contribution of IL-16 genotypes to Taiwan oral cancer risk. Materials and Methods: The genotypes of IL-16 rs4778889, rs11556218, and rs4072111 were revealed among 958 oral cancer cases and 958 control subjects by polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP). Results: First, the distributions of genotypic (p=0.0004) and allelic (p=0.0001) frequencies of IL-16 rs11556218 were significantly different between the case and control groups. In detail, the frequencies of IL-16 rs11556218 TG and GG were 28.1 and 5.8%, respectively, among oral cancer patients, significantly higher compared to those among controls (25.0% and 2.7%, respectively). Second, no difference was observed regarding IL-16 rs4778889 or IL-16 rs4072111. Last, there was a synergistic effect of betel quid chewing behavior and risky IL-16 rs11556218 genotype on oral cancer risk. Conclusion: The study indicates that the IL-16 rs11556218 G allele synergistically interacts with betel quid chewing behavior, contributing to increased risk of oral cancer in Taiwanese.

  • Betel quid chewing
  • genotype
  • interleukin-16
  • oral cancer
  • single nucleotide polymorphism
  • Taiwan

From the viewpoint of epidemiology, oral cancer is the tenth most commonly diagnosed cancer worldwide, with the highest incidence density in Taiwan (1). According to the updated annual report from the Taiwan government, oral cancer is the fourth cause of cancer-related deaths among males in Taiwan and the fifth among all Taiwanese (2). For many years, betel quid chewing habit has been identified as the most effective environmental contributor to oral cancer risk for Taiwanese (3). Although the surgery, therapy and medical caring services for oral cancer have made rapid progress during the past decade, the prevalence and death rate of oral cancer are still very high in Taiwan. Thus, early detection and prediction biomarkers for oral cancer risk are in urgent need.

Interleukin-16 (IL-16) is encoded by the IL-16 gene located on chromosome 15q26.3, composed of 631 amino acids and cleaved by caspase 3 to the active IL-16 protein, comprising the 121 amino acid C-terminal (4-6). IL-16 is in charge of activating several types of cells, including CD4+ T cells, monocytes, macrophages, eosinophils, and dendritic cells, and promotes the secretion of inflammatory cytokines, such as IL-1 (7), TNF-, and IL-15 (8). Interestingly, a significant increase in the IL-16 expression level has been widely reported in a panel of cancer tissues (9-15). In 2008, a genome-wide association study reported that IL-16 polymorphic differences in people may serve as a practical marker for prostate cancer prediction (16). In the next year, Thomas and his colleagues reported that the frequency of the G allele in IL-16 rs11556218 polymorphism can serve as a risk predictor for colorectal and gastric cancer (15), with no gender prevalence in any of them. At the same time, it was shown that women more frequently carrying the T allele in IL-16 rs4072111 had a lower risk of colorectal and gastric cancer compared to those carrying the C allele more (15).

Despite the significant involvement of IL-16 in cancer etiology and pathogenesis, no investigation about the contribution of IL-16 genotypes or phenotypes to oral cancer risk has been performed. Based on what has been published, we are interested to assess whether rs4778889 T/C, rs11556218 T/G and rs4072111 C/T polymorphisms of IL-16 are associated with a higher risk of oral cancer in Taiwan. In addition, we examined the joint effect of betel quid chewing status and particular IL-16 polymorphisms on oral cancer risk.

Materials and Methods

Investigated controls and cases. Briefly, 958 oral cancer cases were recruited at the China Medical University Hospital in central Taiwan (17-19). The demographic indexes of the oral cancer patients, including their histological details, were all graded and defined by expert surgeons. Each of the cancer patients voluntarily provided 5 ml of their peripheral blood and completed a questionnaire that focused on medical history and habits, such as diet, alcohol consumption, areca chewing and smoking. Then, the same number of healthy individuals with no cancer were selected to form the control group matched by age and gender after an initial random sampling from the Health Examination Cohort pool. They too contributed blood and completed the same questionnaire as the cancer patients. Self-reported habits, such as alcohol consumption, areca chewing and smoking were evaluated and classified as categorical variables. The personal frequencies of these personal behaviors, including alcohol consumption, areca chewing and smoking, as more than twice a week for years was recorded as a status/habit. These factors were recorded and are concisely summarized in Table I. The male versus female ratio was 76% to 24% in both control and oral cancer patient groups, perfectly matched with one another. The prognosis status of all the oral cancer patients, such as recurrence, metastasis and survival, were followed at least twice per year after their surgery. The mean age of the patients and the controls was 56.4 (SD=7.5) and 56.8 (SD=8.7) years, showing that the matching was successful, causing a non-significantly differential distribution between the case and control groups. The study was reviewed and approved by the Institutional Review Board (DMR101-IRB1-306).

Oral cancer IL-16 genotyping methodology. Genomic DNA from the peripheral blood leucocytes of all oral cancer patients and matched controls were extracted using the QIAamp Blood Mini Kit (Blossom, Taipei, Taiwan) and further processed in typical polymerase chain reaction (PCR) processes as in our previous papers (20-22). The sequences of designed forward and reverse primers, corresponding restriction enzymes (New England BioLabs, Ipswich, MA, USA) and sizes of PCR products after enzyme digestion for oral cancer IL-16 genotyping identification are shown in Table II. The PCR cycling were set as: i) one cycle at 94°C for 5 min, ii) 35 cycles of 94°C for 30 s, iii) 55°C for 30 s, iv) 72°C for 30 s, and v) a final extension at 72°C for 10 min. The PCR products were run on a 3% agarose gel on 100 Volt for 20 min. The genotyping procedure was performed by three researchers independently and blindly. The repeated results from different researchers within each subject were perfectly consistent.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Selected characteristics of the 958 patients with oral cancer and 958 controls.

Statistical analyses. First, the Student's t-test was used to compare the distribution of ages between the two groups. Second, Pearson's chi-square test was applied to compare the distribution of the IL-16 rs4778889, rs11556218 and rs4072111 genotypes among the subgroups, and to also examine the possible interaction among the indices of interest. Last, the association between the IL-16 rs4778889, rs11556218 or rs4072111 polymorphisms and oral cancer risk were estimated using computing odds ratios (ORs) and their 95% confidence intervals (CIs) using logistic regression analysis. Any difference with the outcome of p<0.05 was considered statistically significant.

Results

Table I summarizes the demographic characteristics of the 1,916 recruited subjects (958 oral cancer cases and 958 non-cancer healthy controls) of this study. There is no significant difference with respect to age and gender, while smoking, alcohol consumption and betel quid chewing all have different distribution between the oral cancer and control cohorts. These differences suggest that smoking, alcohol drinking and betel quid chewing are all risk factors for oral cancer in Taiwan (Table I). With regard to pathological identification, the major tumor sites of oral cancer occurred in the tongue (41.4%) and buccal mucosa (37.2%) (Table I).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Sequences of the designed primers, corresponding restriction enzymes and fragments identifications for genotyping of IL-16 rs4778889, rs11556218 and rs4072111.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Distribution of IL-16 rs4778889, rs11556218 and rs4072111 genotypes among the 958 patients with oral cancer and 958 controls.

In Table III, we have calculated the distributions of genotypic frequencies of the three IL-16 SNPs (rs4778889, rs11556218 and rs4072111) for all the 1916 investigated subjects. First, the allelic frequencies in the rs4778889, rs11556218 and rs4072111 of the control group agreed well with the Hardy-Weinberg equilibrium (all p>0.05). Second, in IL-16 rs4778889, there was no significant difference between the case and control groups concerning the frequency of TT, CT and CC (Table III, top panel, p for trend>0.05). Third, there was a noticeably significant difference in the distribution of IL-16 rs11556218 genotypic frequencies with regards to the TT, TG and GG genotypes between the case and control groups (Table III, middle panel, p for trend=0.0004). Furthermore, we found that TG, GG and TG+ GG genotypes were differentially distributed between the case and control groups, compared to that of the wild-type TT genotype (Table III, middle panel, all p<0.05 and OR>1.00). Last, concerning IL-16 rs4072111, there was no significant difference between the case and control groups with regards to the frequency of the CC, CT and TT genotypes (Table III, bottom panel, p for trend>0.05). Overall, it seems that only the IL-16 rs11556218 polymorphism, and not IL-16 rs4778889 or rs4072111, can serve as a predictive biomarker for higher risk of oral cancer in Taiwan.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Distributions of IL-16 rs4778889, rs11556218 and rs4072111 allelic frequencies among the 958 patients with oral cancer and 958 controls.

To validate the interesting findings presented in Table III, we also examined the distribution of the allelic frequencies in IL-16 rs4778889, rs11556218 and rs4072111 in Table IV. In agreement with the findings in Table III, the variant G allele in IL-16 rs11556218 was associated with a significantly elevated oral cancer risk, compared to the wild-type allele T (OR=1.39, 95%CI=1.17-1.64, p=0.0001) (Table IV, middle panel). In detail, the frequencies of the T and G alleles of IL-16 rs11556218 were 80.1% and 19.9% among the oral cancer patients, respectively, and 84.8% and 15.2%, respectively, among the non-cancer age- and gender-matched healthy controls (Table IV, middle panel). On the contrary, neither the variant C allele of IL-16 rs4778889 nor the variant T allele of IL-16 rs4072111 were associated with and altered oral cancer risk (Table IV, top and bottom panels, respectively).

Since oral cancer can be related with the consumption of betel quid chewing in Taiwan, we were very interested in the interaction between the genotype of IL-16 rs11556218 with betel quid chewing behavior and whether such a combination poses an even higher risk for oral cancer. The joint effect of IL-16 rs11556218 with betel quid chewing habit on oral cancer is shown in Table V. All oral cancer patients and age- and gender-matched controls were stratified according to whether they chew betel quid and their IL-16 rs11556218 genotypes. Interestingly, the results showed that there was no higher risk for non-chewers (Table V, top panel); however, there was a significantly elevated oral cancer risk for the betel quid chewers with a variant TG or GG genotypes in IL-16 rs11556218 (p=0.0013) (Table V, bottom panel).

Discussion

In the current study, we examined the contribution of IL-16 genotypes to elevated oral cancer risk among an extremely large population of Taiwanese, containing 958 oral cancer patients and 958 age-, gender-matched healthy controls. The highlight results showed that IL-16 rs11556218 G carriers were of a statistically higher risk for oral cancer, while this significance was not found for the IL-16 rs4778889 or IL-16 rs4072111 alleles. The IL-16 rs11556218 is a polymorphic site in charge of a missense coding from the wild-type Asn (T) to the variant Lys (G). Notably, IL-16 rs11556218 TG and GG genotypes could potentially serve as novel genomic biomarkers for predicting increased oral cancer risk in Taiwan, where the density of oral cancer is the highest in the world. In 2009, the serum levels of IL-16 were reported to be higher in colorectal cancer and gastric cancer patients; however, no significant genotype-phenotype correlation between IL-16 rs11556218 polymorphisms and serum levels of IL-16 was observed in that study (15). There is no literature available about the expression levels of IL-16 among oral cancer patients. Future studies on the specific genotype-phenotype correlation of IL-16 among Taiwanese will provide useful information for predicting those at higher risk.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table V.

Distribution of IL-16 rs11556218 genotypes among the 958 patients with oral cancer and 958 controls after stratification by betel quid chewing status.

In our study, we further found that the variant genotypes of IL-16 rs11556218 were associated with an elevated oral cancer risk in the group of betel quid chewers, but not in the non-chewers group. These novel findings strongly encourage additional investigations regarding the functional phenotypes of IL-16 rs11556218 and their involvement in oral cancer etiology, as well as the interaction between IL-16 rs11556218 and betel quid chewing.

In the current study, we proposed the variant TG and GG genotypes at IL-16 rs11556218 can serve as practical biomarkers for oral cancer risk prediction in Taiwan. An elevated risk has also been found in several other types of cancer, including nasopharyngeal carcinoma (another important head and neck cancer) (23), gastric cancer (15), hepatocellular carcinoma (24) and colorectal cancer (15) in other populations. It is of great interest for us to investigate whether IL-16 rs11556218 can serve as practical biomarkers for these types of cancer in Taiwan. As for IL-16 rs4778889, it has been found that the C allele of IL-16 rs4778889 is associated with the risk of renal cell carcinoma (25), especially among Asian ethnicities (26); however, this polymorphic site is not a contributor to oral cancer risk prediction.

From the viewpoint of oral cancer genomics, there are several biomarkers in the fields of DNA repair activity (27, 28), extracellular matrix regulation (17, 18), antioxidant capacity (28, 29), cell viability (19). All these, in addition to the immune-responsiveness studied here, are contributors to differential susceptibility of individual patients. These markers can potentially be correlated with information from the systemic recordings found in clinicopathological databases of the oral cancer patients for the prediction of prognosis outcomes, such as survival (30) and metastasis (31). Additional genotype-phenotype correlation studies can help in revealing the biological meanings of these genomic markers, extending our understanding of the etiology of each oral cancer patient, leading to personalized therapeutic options.

In conclusion, the study provides solid evidence that the TG and GG genotypes of IL-16 rs11556218 are associated with increased oral cancer risk among Taiwanese, especially those with betel quid chewing habit. Further studies with larger subjects in diverse ethnic populations are needed to verify our findings. The genotype-phenotype correlation investigations would be very valuable to reveal the contribution of IL-16 to oral carcinogenesis.

Acknowledgements

The Authors are grateful to the Tissue-bank of China Medical University Hospital and doctors/nurses under Prof. Tsai MH's leadership for their excellent sample collection and survey assistance. The technical assistance from Si-Hua Chen, Yu-Hsin Lin, Yi-Ru Huang and Yu-Chen Hsiau, the consultants of statistical analysis from Cheng-Li Lin were also very helpful for the manuscript preparation. This study was supported mainly by research grants from China Medical University Hospital (DMR-108-BC-1) and partially by Taichung Veterans General Hospital (TCVGH-1084906C).

Footnotes

  • Authors' Contributions

    Research design was done by SLC, TCW, and LHT. Patient and questionnaire summaries were provided by SLC, STC, and LHT. Experimental work was done by WYC, CWS, and WZH. Statistical analysis was done by CCY, YCC, and LHY. KCC, TCW, and BDT wrote the manuscript, whereas BDT, CWS, and TCW reviewed it and are responsible for the revision.

  • This article is freely accessible online.

  • Conflicts of Interest

    All Authors declare no conflicts of interest regarding this study.

  • Received March 18, 2020.
  • Revision received April 6, 2020.
  • Accepted April 8, 2020.
  • Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Torre LA,
    2. Bray F,
    3. Siegel RL,
    4. Ferlay J,
    5. Lortet-Tieulent J,
    6. Jemal A
    : Global cancer statistics, 2012. CA Cancer J Clin 65(2): 87-108, 2015. PMID: 25651787. DOI: 10.3322/caac.21262
    OpenUrlCrossRefPubMed
  2. ↵
    1. Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence
    : Cancer Registration Annual Report. Available at: https://www.hpa.gov.tw/Pages/List.aspx?nodeid=269 [Last accessed on March 17th, 2020]
  3. ↵
    1. Ko YC,
    2. Huang YL,
    3. Lee CH,
    4. Chen MJ,
    5. Lin LM,
    6. Tsai CC
    : Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24(10): 450-453, 1995. PMID: 8600280. DOI: 10.1111/j.1600-0714.1995. tb01132.x
    OpenUrlCrossRefPubMed
  4. ↵
    1. Baier M,
    2. Bannert N,
    3. Werner A,
    4. Lang K,
    5. Kurth R
    : Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci USA 94(10): 5273-5277, 1997. PMID: 9144227. DOI: 10.1073/pnas.94.10.5273
    OpenUrlAbstract/FREE Full Text
    1. Drwinga HL,
    2. Toji LH,
    3. Kim CH,
    4. Greene AE,
    5. Mulivor RA
    : NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2. Genomics 16(2): 311-314, 1993. PMID: 8314568. DOI: 10.1006/geno.1993.1190
    OpenUrlCrossRefPubMed
  5. ↵
    1. Zhang Y,
    2. Center DM,
    3. Wu DM,
    4. Cruikshank WW,
    5. Yuan J,
    6. Andrews DW,
    7. Kornfeld H
    : Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem 273(2): 1144-1149, 1998. PMID: 9422780. DOI: 10.1074/jbc.273.2.1144
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Mathy NL,
    2. Scheuer W,
    3. Lanzendorfer M,
    4. Honold K,
    5. Ambrosius D,
    6. Norley S,
    7. Kurth R
    : Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology 100(1): 63-69, 2000. PMID: 10809960. DOI: 10.1046/j.1365-2567.2000.00997.x
    OpenUrlCrossRefPubMed
  7. ↵
    1. Zheng Y,
    2. Cao KY,
    3. Ng SP,
    4. Chua DT,
    5. Sham JS,
    6. Kwong DL,
    7. Ng MH,
    8. Lu L,
    9. Zheng BJ
    : Complementary activation of peripheral natural killer cell immunity in nasopharyngeal carcinoma. Cancer Sci 97(9): 912-919, 2006. PMID: 16805822. DOI: 10.1111/j.1349-7006.2006.00252.x
    OpenUrlCrossRefPubMed
  8. ↵
    1. Kovacs E
    : The serum levels of IL-12 and IL-16 in cancer patients. Relation to the tumour stage and previous therapy. Biomed Pharmacother 55(2): 111-116, 2001. PMID: 11293814. DOI: 10.1016/s0753-3322(00)00023-8
    OpenUrlCrossRefPubMed
    1. Liebrich M,
    2. Guo LH,
    3. Schluesener HJ,
    4. Schwab JM,
    5. Dietz K,
    6. Will BE,
    7. Meyermann R
    : Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors. Arch Immunol Ther Exp (Warsz) 55(1): 41-47, 2007. PMID: 17221335. DOI: 10.1007/s00005-007-0003-0
    OpenUrlCrossRefPubMed
    1. Koike M,
    2. Sekigawa I,
    3. Okada M,
    4. Matsumoto M,
    5. Iida N,
    6. Hashimoto H,
    7. Oshimi K
    : Relationship between CD4(+)/CD8(+) T cell ratio and T cell activation in multiple myeloma: reference to IL-16. Leuk Res 26(8): 705-711, 2002. PMID: 12191564. DOI: 10.1016/s0145-2126(01)00192-8
    OpenUrlCrossRefPubMed
    1. Alexandrakis MG,
    2. Passam FH,
    3. Kyriakou DS,
    4. Christophoridou AV,
    5. Perisinakis K,
    6. Hatzivasili A,
    7. Foudoulakis A,
    8. Castanas E
    : Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity. Am J Hematol 75(2): 101-106, 2004. PMID: 14755377. DOI: 10.1002/ajh.10444
    OpenUrlCrossRefPubMed
    1. Passam FH,
    2. Sfiridaki A,
    3. Pappa C,
    4. Kyriakou D,
    5. Petreli E,
    6. Roussou PA,
    7. Alexandrakis MG
    : Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment. Int J Lab Hematol 30(1): 17-25, 2008. PMID: 18190463. DOI: 10.1111/j.1365-2257.2006.00890.x
    OpenUrlPubMed
    1. Blaschke V,
    2. Reich K,
    3. Middel P,
    4. Letschert M,
    5. Sachse F,
    6. Harwix S,
    7. Neumann C
    : Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides. J Invest Dermatol 113(4): 658-663, 1999. PMID: 10504456. DOI: 10.1046/j.1523-1747.1999.00717.x
    OpenUrlCrossRefPubMed
  9. ↵
    1. Gao LB,
    2. Rao L,
    3. Wang YY,
    4. Liang WB,
    5. Li C,
    6. Xue H,
    7. Zhou B,
    8. Sun H,
    9. Li Y,
    10. Lv ML,
    11. Du XJ,
    12. Zhang L
    : The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis 30(2): 295-299, 2009. PMID: 19073878. DOI: 10.1093/carcin/bgn281
    OpenUrlCrossRefPubMed
  10. ↵
    1. Thomas G,
    2. Jacobs KB,
    3. Yeager M,
    4. Kraft P,
    5. Wacholder S,
    6. Orr N,
    7. Yu K,
    8. Chatterjee N,
    9. Welch R,
    10. Hutchinson A,
    11. Crenshaw A,
    12. Cancel-Tassin G,
    13. Staats BJ,
    14. Wang Z,
    15. Gonzalez-Bosquet J,
    16. Fang J,
    17. Deng X,
    18. Berndt SI,
    19. Calle EE,
    20. Feigelson HS,
    21. Thun MJ,
    22. Rodriguez C,
    23. Albanes D,
    24. Virtamo J,
    25. Weinstein S,
    26. Schumacher FR,
    27. Giovannucci E,
    28. Willett WC,
    29. Cussenot O,
    30. Valeri A,
    31. Andriole GL,
    32. Crawford ED,
    33. Tucker M,
    34. Gerhard DS,
    35. Fraumeni JF Jr..,
    36. Hoover R,
    37. Hayes RB,
    38. Hunter DJ,
    39. Chanock SJ
    : Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40(3): 310-315, 2008. PMID: 18264096. DOI: 10.1038/ng.91
    OpenUrlCrossRefPubMed
  11. ↵
    1. Shih LC,
    2. Li CH,
    3. Sun KT,
    4. Chen LY,
    5. Hsu CL,
    6. Hung YW,
    7. Wu CN,
    8. Hsia TC,
    9. Shen TC,
    10. Chang WS,
    11. Shih TC,
    12. Tsai CW,
    13. Bau DT
    : Association of matrix metalloproteinase-7 genotypes to the risk of oral cancer in Taiwan. Anticancer Res 38(4): 2087-2092, 2018. PMID: 29599326. DOI: 10.21873/anticanres.12448
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Tsai CW,
    2. Hsu HM,
    3. Wang YC,
    4. Chang WS,
    5. Shih LC,
    6. Sun KT,
    7. Hung YW,
    8. Yang YC,
    9. Gong CL,
    10. Bau DT
    : Contribution of MMP2 promoter genotypes to oral cancer susceptibility, recurrence and metastasis in Taiwan. Anticancer Res 38(12): 6821-6826, 2018. PMID: 30504396. DOI: 10.21873/anticanres. 13055
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Shih LC,
    2. Tsai CW,
    3. Sun KT,
    4. Hsu HM,
    5. Shen TC,
    6. Tsai YT,
    7. Chang WS,
    8. Lin ML,
    9. Wang YC,
    10. Gong CL,
    11. Bau DT
    : Association of caspase-8 genotypes with oral cancer risk in Taiwan. In Vivo 33(4): 1151-1156, 2019. PMID: 31280204. DOI: 10.21873/invivo.11585
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Hsu SW,
    2. Gong CL,
    3. Hsu HM,
    4. Chao CC,
    5. Wang YC,
    6. Chang WS,
    7. Tsai YT,
    8. Shih LC,
    9. Tsai CW,
    10. Bau DT
    : Contribution of matrix metalloproteinase-2 promoter genotypes to nasopharyngeal cancer susceptibility and metastasis in Taiwan. Cancer Genomics Proteomics 16(4): 287-292, 2019. PMID: 31243109. DOI: 10.21873/cgp.20133
    OpenUrlAbstract/FREE Full Text
    1. Pei JS,
    2. Chang WS,
    3. Hsu PC,
    4. Chen CC,
    5. Chin YT,
    6. Huang TL,
    7. Hsu YN,
    8. Kuo CC,
    9. Wang YC,
    10. Tsai CW,
    11. Gong CL,
    12. Bau DT
    : Significant association between the MiR146a genotypes and susceptibility to childhood acute lymphoblastic leukemia in Taiwan. Cancer Genomics Proteomics 17(2): 175-180, 2020. PMID: 32108040. DOI: 10.21873/cgp.20178
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Hu PS,
    2. Wang YC,
    3. Liao CH,
    4. Hsia NY,
    5. Wu MF,
    6. Yang JS,
    7. Yu CC,
    8. Chang WS,
    9. Bau DT,
    10. Tsai CW
    : The association of MMP7 genotype with pterygium. In Vivo 34(1): 51-56, 2020. PMID: 31882462. DOI: 10.21873/invivo.11744
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Gao LB,
    2. Liang WB,
    3. Xue H,
    4. Rao L,
    5. Pan XM,
    6. Lv ML,
    7. Bai P,
    8. Fang WL,
    9. Liu J,
    10. Liao M,
    11. Zhang L
    : Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta 409(1-2): 132-135, 2009. PMID: 19758567. DOI: 10.1016/j.cca.2009.09.017
    OpenUrlCrossRefPubMed
  17. ↵
    1. Li S,
    2. Deng Y,
    3. Chen ZP,
    4. Huang S,
    5. Liao XC,
    6. Lin LW,
    7. Li H,
    8. Peng T,
    9. Qin X,
    10. Zhao JM
    : Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infect Genet Evol 11(8): 2083-2088, 2011. PMID: 22019522. DOI: 10.1016/j.meegid. 2011.09.025
    OpenUrlPubMed
  18. ↵
    1. Wang Z,
    2. Xu Y,
    3. Zhu S
    : Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population. Int J Clin Exp Pathol 8(11): 15228-15233, 2015. PMID: 26823871
    OpenUrl
  19. ↵
    1. Zhou T,
    2. Li H,
    3. Xie WJ,
    4. Zhong Z,
    5. Zhong H,
    6. Lin ZJ
    : Association of methylenetetrahydrofolate reductase, vitamin D receptor, and interleukin-16 gene polymorphisms with renal cell carcinoma risk. Technol Cancer Res Treat 18: 1533033819859413, 2019. PMID: 31242814. DOI: 10.1177/1533033819859413
    OpenUrl
  20. ↵
    1. Tsai CW,
    2. Chang WS,
    3. Liu JC,
    4. Tsai MH,
    5. Lin CC,
    6. Bau DT
    : Contribution of DNA double-strand break repair gene XRCC3 genotypes to oral cancer susceptibility in Taiwan. Anticancer Res 34(6): 2951-2956, 2014. PMID: 24922659.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Tsai CW,
    2. Tsai MH,
    3. Tsou YA,
    4. Shih LC,
    5. Tseng HC,
    6. Chang WS,
    7. Ho CY,
    8. Lee HZ,
    9. Bau DT
    : The joint effect of smoking and hOGG1 genotype on oral cancer in Taiwan. Anticancer Res 32(9): 3799-3803, 2012. PMID: 22993322.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Barroso Duarte EC,
    2. Da Silva MS,
    3. Gomez MV,
    4. Gomez RS
    : GSTT1 polymorphism and oral leukoplakia. Anticancer Res 26(1A): 427-430, 2006. PMID: 16475728.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Suzuki H,
    2. Tamaki T,
    3. Nishio M,
    4. Beppu S,
    5. Mukoyama N,
    6. Hanai N,
    7. Nishikawa D,
    8. Koide Y,
    9. Hasegawa Y
    : Peak of standardized uptake value in oral cancer predicts survival adjusting for pathological stage. In Vivo 32(5): 1193-1198, 2018. PMID: 30150443. DOI: 10.21873/invivo.11363
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Noguti J,
    2. De Moura CF,
    3. De Jesus GP,
    4. Da Silva VH,
    5. Hossaka TA,
    6. Oshima CT,
    7. Ribeiro DA
    : Metastasis from oral cancer: an overview. Cancer Genomics Proteomics 9(5): 329-335, 2012. PMID: 22990112.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

In Vivo: 34 (4)
In Vivo
Vol. 34, Issue 4
July-August 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Interaction of Interleukin-16 Genotypes With Betel Quid Chewing Behavior on Oral Cancer in Taiwan
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Interaction of Interleukin-16 Genotypes With Betel Quid Chewing Behavior on Oral Cancer in Taiwan
LIANG-CHUN SHIH, WEN-SHIN CHANG, HSU-TUNG LEE, YUN-CHI WANG, ZHI-HONG WANG, CHE-YI CHAO, CHIEN-CHIH YU, HUI-YI LIN, TE-CHUN SHEN, CHIEN-CHUNG KUO, CHIA-WEN TSAI, DA-TIAN BAU
In Vivo Jul 2020, 34 (4) 1759-1764; DOI: 10.21873/invivo.11969

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Interaction of Interleukin-16 Genotypes With Betel Quid Chewing Behavior on Oral Cancer in Taiwan
LIANG-CHUN SHIH, WEN-SHIN CHANG, HSU-TUNG LEE, YUN-CHI WANG, ZHI-HONG WANG, CHE-YI CHAO, CHIEN-CHIH YU, HUI-YI LIN, TE-CHUN SHEN, CHIEN-CHUNG KUO, CHIA-WEN TSAI, DA-TIAN BAU
In Vivo Jul 2020, 34 (4) 1759-1764; DOI: 10.21873/invivo.11969
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Significant Association of Cyclin D1 Promoter Genotypes With Asthma Susceptibility in Taiwan
  • Interaction of DNA Repair Gene XPC With Smoking and Betel Quid Chewing Behaviors of Oral Cancer
  • Interleukin-13 Promoter Genotypes and Taiwanese Breast Cancer Susceptibility
  • Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan
  • Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan
  • Contribution of Matrix Metalloproteinase-9 rs3918242 Genotypes to Childhood Leukemia Risk
  • Google Scholar

More in this TOC Section

  • Enhancement of Wound Healing Efficacy by Chitosan-based Hydrocolloid on Sprague Dawley Rats
  • Expression of ALCAM in Clinical Colon Cancer and Relationship With Patients’ Treatment Responses
  • A Pilot Study of the Association VDR Polymorphisms With Primary Hyperparathyroidism
Show more Experimental Studies

Similar Articles

Keywords

  • Betel quid chewing
  • genotype
  • interleukin-16
  • oral cancer
  • single nucleotide polymorphism
  • Taiwan
In Vivo

© 2023 In Vivo

Powered by HighWire